HETEROCYCLIC HYDROXYMIC ACIDS AS PROTEIN-DEACETYLASE INHIBITORS AND DOUBLE INHIBITORS OF PROTEIN-DEACETYLASE-PROTEIN-KINASE AND THE APPLICATION METHODS
The present invention relates to novel hydroxamic acids which are specific histone deacetylase (HDAC) inhibitors and/or TTK/Mps1 kinase inhibitors, including pharmaceutically acceptable salts thereof, which are useful for modulating HDAC and/or TTK/Mps1 kinase activity, pharmaceutical compositions comprising these compounds, and processes for their preparation.